CN113999807A - Construction method of recombinant strain and application of recombinant strain in production of itaconic acid - Google Patents
Construction method of recombinant strain and application of recombinant strain in production of itaconic acid Download PDFInfo
- Publication number
- CN113999807A CN113999807A CN202111287718.XA CN202111287718A CN113999807A CN 113999807 A CN113999807 A CN 113999807A CN 202111287718 A CN202111287718 A CN 202111287718A CN 113999807 A CN113999807 A CN 113999807A
- Authority
- CN
- China
- Prior art keywords
- cada
- pcdfduet
- recombinant strain
- itaconic acid
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 title claims abstract description 37
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 238000010276 construction Methods 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 18
- 108010048430 aconitate decarboxylase Proteins 0.000 claims abstract description 14
- 230000035772 mutation Effects 0.000 claims abstract description 9
- 241000588724 Escherichia coli Species 0.000 claims abstract description 8
- 101100276041 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) ctpD gene Proteins 0.000 claims abstract description 8
- 101150008667 cadA gene Proteins 0.000 claims abstract description 8
- 238000002741 site-directed mutagenesis Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 14
- 239000013612 plasmid Substances 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 230000003321 amplification Effects 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 7
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 5
- 229940091181 aconitic acid Drugs 0.000 claims description 5
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 238000002703 mutagenesis Methods 0.000 claims description 2
- 231100000350 mutagenesis Toxicity 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims 2
- 239000000047 product Substances 0.000 abstract description 10
- 238000000855 fermentation Methods 0.000 abstract description 8
- 230000004151 fermentation Effects 0.000 abstract description 8
- 239000000758 substrate Substances 0.000 abstract description 4
- 238000006555 catalytic reaction Methods 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 3
- 230000036983 biotransformation Effects 0.000 abstract description 2
- 239000006227 byproduct Substances 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 238000010189 synthetic method Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 8
- 102100038248 Cis-aconitate decarboxylase Human genes 0.000 description 6
- 241001465318 Aspergillus terreus Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 3
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 2
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- 229940091179 aconitate Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- DVWVZSJAYIJZFI-FXQIFTODSA-N Ala-Arg-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O DVWVZSJAYIJZFI-FXQIFTODSA-N 0.000 description 1
- NXSFUECZFORGOG-CIUDSAMLSA-N Ala-Asn-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXSFUECZFORGOG-CIUDSAMLSA-N 0.000 description 1
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- GKAZXNDATBWNBI-DCAQKATOSA-N Ala-Met-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N GKAZXNDATBWNBI-DCAQKATOSA-N 0.000 description 1
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 1
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 1
- XPBVBZPVNFIHOA-UVBJJODRSA-N Ala-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 XPBVBZPVNFIHOA-UVBJJODRSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- AGVNTAUPLWIQEN-ZPFDUUQYSA-N Arg-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AGVNTAUPLWIQEN-ZPFDUUQYSA-N 0.000 description 1
- LLQIAIUAKGNOSE-NHCYSSNCSA-N Arg-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N LLQIAIUAKGNOSE-NHCYSSNCSA-N 0.000 description 1
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 1
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 1
- OLISTMZJGQUOGS-GMOBBJLQSA-N Asn-Ile-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N OLISTMZJGQUOGS-GMOBBJLQSA-N 0.000 description 1
- HFPXZWPUVFVNLL-GUBZILKMSA-N Asn-Leu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFPXZWPUVFVNLL-GUBZILKMSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- BKXPJCBEHWFSTF-ACZMJKKPSA-N Asp-Gln-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O BKXPJCBEHWFSTF-ACZMJKKPSA-N 0.000 description 1
- SPKCGKRUYKMDHP-GUDRVLHUSA-N Asp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N SPKCGKRUYKMDHP-GUDRVLHUSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- XXAMCEGRCZQGEM-ZLUOBGJFSA-N Asp-Ser-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O XXAMCEGRCZQGEM-ZLUOBGJFSA-N 0.000 description 1
- ZQFZEBRNAMXXJV-KKUMJFAQSA-N Asp-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O ZQFZEBRNAMXXJV-KKUMJFAQSA-N 0.000 description 1
- UXRVDHVARNBOIO-QSFUFRPTSA-N Asp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)N UXRVDHVARNBOIO-QSFUFRPTSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- XGIAHEUULGOZHH-GUBZILKMSA-N Cys-Arg-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N XGIAHEUULGOZHH-GUBZILKMSA-N 0.000 description 1
- ZJBWJHQDOIMVLM-WHFBIAKZSA-N Cys-Cys-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O ZJBWJHQDOIMVLM-WHFBIAKZSA-N 0.000 description 1
- LBOLGUYQEPZSKM-YUMQZZPRSA-N Cys-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N LBOLGUYQEPZSKM-YUMQZZPRSA-N 0.000 description 1
- JDHMXPSXWMPYQZ-AAEUAGOBSA-N Cys-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N JDHMXPSXWMPYQZ-AAEUAGOBSA-N 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- FKXCBKCOSVIGCT-AVGNSLFASA-N Gln-Lys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FKXCBKCOSVIGCT-AVGNSLFASA-N 0.000 description 1
- UESYBOXFJWJVSB-AVGNSLFASA-N Gln-Phe-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O UESYBOXFJWJVSB-AVGNSLFASA-N 0.000 description 1
- KUBFPYIMAGXGBT-ACZMJKKPSA-N Gln-Ser-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KUBFPYIMAGXGBT-ACZMJKKPSA-N 0.000 description 1
- RLZBLVSJDFHDBL-KBIXCLLPSA-N Glu-Ala-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RLZBLVSJDFHDBL-KBIXCLLPSA-N 0.000 description 1
- VTTSANCGJWLPNC-ZPFDUUQYSA-N Glu-Arg-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VTTSANCGJWLPNC-ZPFDUUQYSA-N 0.000 description 1
- WOSRKEJQESVHGA-CIUDSAMLSA-N Glu-Arg-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O WOSRKEJQESVHGA-CIUDSAMLSA-N 0.000 description 1
- PXHABOCPJVTGEK-BQBZGAKWSA-N Glu-Gln-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O PXHABOCPJVTGEK-BQBZGAKWSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- YVYVMJNUENBOOL-KBIXCLLPSA-N Glu-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N YVYVMJNUENBOOL-KBIXCLLPSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- LHIPZASLKPYDPI-AVGNSLFASA-N Glu-Phe-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LHIPZASLKPYDPI-AVGNSLFASA-N 0.000 description 1
- WIKMTDVSCUJIPJ-CIUDSAMLSA-N Glu-Ser-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WIKMTDVSCUJIPJ-CIUDSAMLSA-N 0.000 description 1
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 1
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 1
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 1
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- DJTXYXZNNDDEOU-WHFBIAKZSA-N Gly-Asn-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN)C(=O)N DJTXYXZNNDDEOU-WHFBIAKZSA-N 0.000 description 1
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- RAVLQPXCMRCLKT-KBPBESRZSA-N His-Gly-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RAVLQPXCMRCLKT-KBPBESRZSA-N 0.000 description 1
- UIRUVUUGUYCMBY-KCTSRDHCSA-N His-Trp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CN=CN3)N UIRUVUUGUYCMBY-KCTSRDHCSA-N 0.000 description 1
- CKONPJHGMIDMJP-IHRRRGAJSA-N His-Val-His Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 CKONPJHGMIDMJP-IHRRRGAJSA-N 0.000 description 1
- CISBRYJZMFWOHJ-JBDRJPRFSA-N Ile-Ala-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)N CISBRYJZMFWOHJ-JBDRJPRFSA-N 0.000 description 1
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 1
- ATXGFMOBVKSOMK-PEDHHIEDSA-N Ile-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N ATXGFMOBVKSOMK-PEDHHIEDSA-N 0.000 description 1
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
- UAQSZXGJGLHMNV-XEGUGMAKSA-N Ile-Gly-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N UAQSZXGJGLHMNV-XEGUGMAKSA-N 0.000 description 1
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 1
- PRTZQMBYUZFSFA-XEGUGMAKSA-N Ile-Tyr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)O)N PRTZQMBYUZFSFA-XEGUGMAKSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 1
- PBCHMHROGNUXMK-DLOVCJGASA-N Leu-Ala-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 PBCHMHROGNUXMK-DLOVCJGASA-N 0.000 description 1
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 1
- IGUOAYLTQJLPPD-DCAQKATOSA-N Leu-Asn-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IGUOAYLTQJLPPD-DCAQKATOSA-N 0.000 description 1
- BAJIJEGGUYXZGC-CIUDSAMLSA-N Leu-Asn-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N BAJIJEGGUYXZGC-CIUDSAMLSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 1
- KVOFSTUWVSQMDK-KKUMJFAQSA-N Leu-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 KVOFSTUWVSQMDK-KKUMJFAQSA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 108010022337 Leucine Enkephalin Proteins 0.000 description 1
- PAMDBWYMLWOELY-SDDRHHMPSA-N Lys-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O PAMDBWYMLWOELY-SDDRHHMPSA-N 0.000 description 1
- DLCAXBGXGOVUCD-PPCPHDFISA-N Lys-Thr-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DLCAXBGXGOVUCD-PPCPHDFISA-N 0.000 description 1
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 1
- MTBVQFFQMXHCPC-CIUDSAMLSA-N Met-Glu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MTBVQFFQMXHCPC-CIUDSAMLSA-N 0.000 description 1
- MPCKIRSXNKACRF-GUBZILKMSA-N Met-Pro-Asn Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O MPCKIRSXNKACRF-GUBZILKMSA-N 0.000 description 1
- IHRFZLQEQVHXFA-RHYQMDGZSA-N Met-Thr-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCCN IHRFZLQEQVHXFA-RHYQMDGZSA-N 0.000 description 1
- LPNWWHBFXPNHJG-AVGNSLFASA-N Met-Val-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN LPNWWHBFXPNHJG-AVGNSLFASA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010047562 NGR peptide Proteins 0.000 description 1
- CSDMCMITJLKBAH-SOUVJXGZSA-N Phe-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O CSDMCMITJLKBAH-SOUVJXGZSA-N 0.000 description 1
- PTDAGKJHZBGDKD-OEAJRASXSA-N Phe-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O PTDAGKJHZBGDKD-OEAJRASXSA-N 0.000 description 1
- KQUMFXGQTSAEJE-PMVMPFDFSA-N Phe-Trp-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 KQUMFXGQTSAEJE-PMVMPFDFSA-N 0.000 description 1
- GRIRJQGZZJVANI-CYDGBPFRSA-N Pro-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1 GRIRJQGZZJVANI-CYDGBPFRSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- FYPGHGXAOZTOBO-IHRRRGAJSA-N Pro-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H]2CCCN2 FYPGHGXAOZTOBO-IHRRRGAJSA-N 0.000 description 1
- UIUWGMRJTWHIJZ-ULQDDVLXSA-N Pro-Tyr-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCCN)C(=O)O UIUWGMRJTWHIJZ-ULQDDVLXSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- MMGJPDWSIOAGTH-ACZMJKKPSA-N Ser-Ala-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MMGJPDWSIOAGTH-ACZMJKKPSA-N 0.000 description 1
- FIDMVVBUOCMMJG-CIUDSAMLSA-N Ser-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO FIDMVVBUOCMMJG-CIUDSAMLSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 1
- UOLGINIHBRIECN-FXQIFTODSA-N Ser-Glu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UOLGINIHBRIECN-FXQIFTODSA-N 0.000 description 1
- QKQDTEYDEIJPNK-GUBZILKMSA-N Ser-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO QKQDTEYDEIJPNK-GUBZILKMSA-N 0.000 description 1
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 1
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 1
- FZXOPYUEQGDGMS-ACZMJKKPSA-N Ser-Ser-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZXOPYUEQGDGMS-ACZMJKKPSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 1
- OYTNZCBFDXGQGE-XQXXSGGOSA-N Thr-Gln-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O OYTNZCBFDXGQGE-XQXXSGGOSA-N 0.000 description 1
- ONNSECRQFSTMCC-XKBZYTNZSA-N Thr-Glu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ONNSECRQFSTMCC-XKBZYTNZSA-N 0.000 description 1
- WRUWXBBEFUTJOU-XGEHTFHBSA-N Thr-Met-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O)N)O WRUWXBBEFUTJOU-XGEHTFHBSA-N 0.000 description 1
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 1
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 1
- YRSOERSDNRSCBC-XIRDDKMYSA-N Trp-His-Cys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CS)C(=O)O)N YRSOERSDNRSCBC-XIRDDKMYSA-N 0.000 description 1
- SGFIXFAHVWJKTD-KJEVXHAQSA-N Tyr-Arg-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SGFIXFAHVWJKTD-KJEVXHAQSA-N 0.000 description 1
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 1
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 1
- MDYSKHBSPXUOPV-JSGCOSHPSA-N Val-Gly-Phe Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N MDYSKHBSPXUOPV-JSGCOSHPSA-N 0.000 description 1
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 1
- NSUUANXHLKKHQB-BZSNNMDCSA-N Val-Pro-Trp Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 NSUUANXHLKKHQB-BZSNNMDCSA-N 0.000 description 1
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 1
- SUGRIIAOLCDLBD-ZOBUZTSGSA-N Val-Trp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SUGRIIAOLCDLBD-ZOBUZTSGSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229920006238 degradable plastic Polymers 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 108010025801 glycyl-prolyl-arginine Proteins 0.000 description 1
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002455 scale inhibitor Substances 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 238000012868 site-directed mutagenesis technique Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 1
- 108010000998 wheylin-2 peptide Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01006—Aconitate decarboxylase (4.1.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a construction method of a recombinant strain and application thereof in producing itaconic acid, which mutates 470-position Arg of a natural aconitate decarboxylase gene cadA into Glu by site-directed mutagenesis of the aconitate decarboxylase gene cadA, and then transfers the Glu into escherichia coli for heterologous expression. The site-directed mutagenesis uses a large primer PCR method, and the method has the advantages of simple and convenient operation, high mutation rate and lower cost. Compared with conventional fermentation, the method for producing the itaconic acid uses a whole-cell catalysis method, can reduce the production cost, shorten the production time and effectively improve the yield of the itaconic acid. In addition, the substrate is easy to obtain, byproducts generated by biotransformation are less, purification is convenient, the defect of complex product of the traditional synthetic method is effectively overcome, and the method has wide application prospect in industrial production.
Description
Technical Field
The invention belongs to the fields of molecular biology and genetic engineering, and particularly relates to a construction method of a recombinant strain and application of the recombinant strain in production of itaconic acid.
Background
The aconitate decarboxylase can convert aconitate into itaconic acid, and plays an important role in the processes of connecting natural immunity and metabolism and producing itaconic acid by a biological method. Itaconic acid (itaconic acid and methylene succinic acid) is an unsaturated dicarboxylic acid, is an important industrial raw material and additive in the chemical industry field, and is widely applied to the aspects of producing plastics, chemical fibers, super adsorbents, latex, scale inhibitors and the like as a construction module. Itaconic acid has gained increasing attention as a renewable material. In 2004, itaconic acid was selected by the U.S. department of energy as one of the most promising 12 bio-based platform compounds. At present, the worldwide capacity of itaconic acid is 5 ten thousand tons/year, and at least 3 ten thousand tons of gaps are faced, and itaconic acid can replace acrylic acid and methacrylic acid to be used for producing degradable plastics, the future demand of itaconic acid will continue to increase rapidly, and the itaconic acid is an important organic acid from biomass with wide application prospect.
At present, the dominant method for industrially producing itaconic acid at home and abroad is an aspergillus terreus fermentation method. However, compared with other organic acid fermentation production, the fermentation unit for producing itaconic acid by fermentation of aspergillus terreus is still lower internationally at present because: 1) the fermentation time of the aspergillus terreus is long, and the space-time yield is not high; 2) acn is localized to the mitochondria and cadA is localized to the cytoplasm in fungal cells, and the difference in localization of the two enzymes makes diffusion and reaction of the substrates of the two enzymes with the intermediate more difficult. Therefore, the researchers select escherichia coli as a host bacterium for producing itaconic acid, which has many advantages, however, the pH stability of key enzyme is poor, the substrate conversion rate is low, the production efficiency is low, and the escherichia coli as a production host can not be compared with the aspergillus terreus fermentation economically in terms of titer and yield.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a construction method of a recombinant strain and application thereof in producing itaconic acid, wherein the aconitate decarboxylase is rationally analyzed, the site-specific mutagenesis is carried out by adopting a large primer PCR technology, the aconitate decarboxylase gene cadA which is subjected to site-specific modification is subjected to enzyme digestion by DpnI, after enzyme digestion is carried out for 1h at 37 ℃, the recombinant plasmid is transformed into escherichia coli BL21 (DE 3), a recombinant strain pCDFduet-cadA (R470E) is successfully obtained, and after the whole cell catalytic reaction, the itaconic acid production capacity is improved by 28.74% under the condition of pH 5.0 and by 8.43% under the condition of pH 5.5.
In order to solve the problems of the prior art, the invention adopts the technical scheme that:
a method for constructing a recombinant strain pCDFduet-cadA (R470E), comprising the following steps:
step 1, designing primers
Designing a mutation site by rational analysis of the aconitate decarboxylase gene cadA, and designing a primer by using Snapgene software;
step 2, construction of recombinant plasmid
Carrying out site-directed mutagenesis by using the primer designed in the step 1, and carrying out mutagenesis by using pCDFduet-cadA as a template to obtain a recombinant plasmid pCDFduet-cadA (R470E);
step 3, constructing recombinant strains
3ul of the recombinant plasmid pCDFduet-cadA (R470E) constructed in the step 2 is taken and transformed into 30ul of escherichia coli competent cells, the escherichia coli competent cells are stood for 20min on ice, and immediately placed on the ice for cooling for 5min after being thermally shocked in water bath at 42 ℃ for 50s, and 1ml of LB culture medium (without adding antibiotics) is added; shaking the bacteria at 37 ℃ and 200r/min for 1 h; centrifuging at 5000R/min for 3min, discarding 900ul of supernatant, resuspending the thallus with the rest culture medium, lightly spreading on streptomycin plate with sterile coating rod, culturing overnight at 37 deg.C by inversion in incubator, and selecting positive colony to obtain recombinant strain pCDFduet-cadA (R470E).
As a modification, the primers described in step 1 are respectively as follows:
R470E-F:5’-CTGGTGCTGGGCCTGGATGAACTGACAGATATTAGC -3’
R470E-R:5’-GGTTCAGGGCAGGGTCGTTAAAT -3’。
the improvement is that the two rounds of PCR amplification conditions of the mutation in the step 2 are the same as the amplification system, and the amplification conditions are 95 ℃, 30s and 1 cycle; 95 ℃, 15s, 56 ℃, 15s, 72 ℃, 30s and 30 cycles; 72 ℃, 5min, 1 cycle; an amplification system: ddH2O20.5. mu.l, template 0.5. mu.l, corresponding primers 2. mu.l each, and 2xPhanta Max Master Mix (Dye Plus) 25. mu.l.
The recombinant strain pCDFduet-cadA (R470E) is applied to producing itaconic acid.
As an improvement, the steps of the application are as follows:
transferring the recombinant strain pCDFduet-cadA (R470E) into 10ml of liquid LB culture medium according to the inoculum size of 1%, shaking and culturing at 37 ℃ overnight, transferring the recombinant strain pCDFduet-cadA into 100ml of liquid LB culture medium according to the inoculum size of 1% the next day, shaking and culturing at 37 ℃ for 18h, centrifuging at 4 ℃ and 4500R/min for 15min, discarding the supernatant, re-suspending the thallus by PBS buffer solution, centrifuging at 4 ℃ and 5000R/min for 10min, discarding the supernatant, and preparing the thallus into OD (OD) by PBS60060, preparing bacterial liquid for later use;
step two, reaction system: 400 mul of 0.5M aconitic acid, 1000 mul of OD 60060 bacterial liquid and 600 mul of PBS are reacted for 24 hours in a shaking incubator with the temperature of 35 ℃ and the speed of 200r/min, the reaction liquid is detected by a high performance liquid chromatograph, and the itaconic acid detection method comprises the following steps: aminex HPX-87H type chromatographic column (300X 7.8 mm, 9 μm) with a mobile phase of 0.008 mol/L sulfuric acid; the flow rate is 0.6mL min < -1 >; the detection wavelength is 210 nm; the column oven temperature was 60 ℃.
After detection, the result shows that the recombinant strain pCDFduet-cadA (R470E) produces mutated aconitate decarboxylase, the itaconic acid production capacity of the enzyme is improved by 28.74% under the condition of pH 5.0 and is improved by 8.43% under the condition of pH 5.5 (as shown in figure 3, the itaconic acid yield is calculated by using an established standard curve, the molar conversion rate is the ratio of the generated itaconic acid moles to the consumed aconitate moles, and the relative yield is calculated by taking pCDFduet-cadA as a reference).
Has the advantages that:
the invention discloses a construction method of a recombinant strain and application thereof in producing itaconic acid. The in vitro site-directed mutagenesis technique is used to introduce the desired changes (usually those characterizing favorable directions) including base addition, deletion, point mutation, etc. into the DNA fragment of interest (which may be a genome or a plasmid) by means of polymerase chain reaction, etc. The site-directed mutation can rapidly and efficiently improve the character and the characterization of target protein expressed by DNA, and is a very useful means in gene research work. Compared with the conventional fermentation, the whole-cell catalysis method adopted by the invention can reduce the production cost and shorten the production time. In addition, the substrate is easy to obtain, byproducts generated by biotransformation are less, purification is convenient, the defect of complex product of the traditional synthetic method is overcome, and the method has wide application prospect in industrial production.
1. Compared with the prior key enzyme aconitate decarboxylase in the itaconic acid synthesis path, the aconitate decarboxylase modified by mutation has better catalytic activity, saves the production cost and is more suitable for the requirement of industrial production.
2. The large primer PCR method used in site-directed mutagenesis has almost no special limitation, high success rate, simplified operation process and saved time.
3. The related experiment operation process is mild and harmless to the environment, equipment and operators.
Drawings
FIG. 1 is a diagram of a large primer PCR nucleic acid electrophoresis, (a) shows a one-round PCR product, and (b) shows a two-round PCR product;
FIG. 2 is an SDS-PAGE of aconitate decarboxylase after whole cell culture of the recombinant strain pCDFduet-cadA (R470E) in example 2;
FIG. 3 is a graph showing the comparison between pCDFduet-cadA and pCDFduet-cadA (R470E) under the same conditions for the production of itaconic acid, wherein (a) shows reaction pH 5.0, and (b) shows reaction pH 5.5.
Detailed Description
The present invention is further described in the following description of the specific embodiments, which is not intended to limit the invention, but various modifications and improvements can be made by those skilled in the art according to the basic idea of the invention, within the scope of the invention, as long as they do not depart from the basic idea of the invention.
The techniques not mentioned in the examples are conventional in the art, and further, materials such as Escherichia coli BL21 (DE 3), pCDF-duet1, 2xPHanta Max Master Mix (Dye Plus), dNTPs and the like used are commercial products and can be directly purchased.
The PBS buffer used in the examples had a pH of 7.0.
In the examples, the concentrations of the reagents such as aconitic acid refer to the final concentration in the system.
Example 1 site-directed mutagenesis of the aconitate decarboxylase Gene cadA
The aconitic acid desaturase is derived from aspergillus terreus, and the amino acid sequence is shown as SEQ NO. 1: MTKQSADSNAKSGVTSEICHWASNLATDDIPSDVLERAKYLILDGIACAWVGARVPWSEKYVQATMSFEPPGACRVIGYGQKLGPVAAAMTNSAFIQATELDDYHSEAPLHSASIVLPAVFAASEVLAEQGKTISGIDVILAAIVGFESGPRIGKAIYGSDLLNNGWHCGAVYGAPAGALATGKLLGLTPDSMEDALGIACTQACGLMSAQYGGMVKRVQHGFAARNGLLGGLLAHGGYEAMKGVLERSYGGFLKMFTKGNGREPPYKEEEVVAGLGSFWHTFTIRIKLYACCGLVHGPVEAIENLQGRYPELLNRANLSNIRHVHVQLSTASNSHCGWIPEERPISSIAGQMSVAYILAVQLVDQQCLLSQFSEFDDNLERPEVWDLARKVTSSQSEEFDQDGNCLSAGRVRIEFNDGSSITESVEKPLGVKEPMPNERILHKYRTLAGSVTDESRVKEIEDLVLGLDRLTDISPLLELLNCPVKSPLV
(1) Designing a primer, namely carrying out site-directed mutagenesis by using a large primer PCR technology through rational design of a aconitate decarboxylase gene cadA, and designing the primer by utilizing Snapgene software as follows:
R470E-F:5’-CTGGTGCTGGGCCTGGATGAACTGACAGATATTAGC -3’
R470E-R:5’-GGTTCAGGGCAGGGTCGTTAAAT -3’。
EXAMPLE 2 construction of recombinant plasmid pCDFduet-cadA (R470E)
(2) PCR amplification was performed using pCDFduet-cadA as a template and primers R470E-F, R470E-R provided in example 1 under the following conditions: 95 ℃, 30s, 1 cycle; 95 ℃, 15s, 56 ℃, 15s, 72 ℃, 30s and 30 cycles; 72 ℃, 5min, 1 cycle. An amplification system: ddH220.5 mul of O, 0.5 mul of template, 2 mul of each primer R470E-F, R470E-R, and 25 mul of 2xPHANTA Max Master Mix (Dye Plus) to amplify a PCR product of 300 bp; the conditions for the two-round PCR amplification are as follows: 95 ℃, 30s, 1 cycle; 30 cycles of 95 ℃, 15s, 56 ℃, 15s, 72 ℃, 6 min; 72 ℃, 5min, 1 cycle. An amplification system: ddH2Mu.l of O23, 1. mu.l of template, 1. mu.l of PCR product, 25. mu.l of 2xPhanta Max Master Mix (Dye Plus), and PCR product pCDFduet-cadA (R470E) containing the R470E mutation site. The target gene was recovered using an agarose gel recovery cassette, and the agarose gel electrophoresis of the large primer PCR is shown in FIG. 1, wherein (a) is a PCR product of one round, i.e., 300bp large primer, and (b) is a PCR product of two rounds, i.e., recombinant plasmid pCDFduet-cadA (R470E).
EXAMPLE 2 acquisition of recombinant Strain pCDFduet-cadA (R470E)
The recombinant plasmid pCDFduet-cadA (R470E) constructed in example 1 was digested with Dpn I, and the digestion system: the recombinant plasmid pCDFduet-cadA (R470E) 8.5. mu.l, Dpn I0.5. mu.l, 10xQuick Cut Buffer 1. mu.l, was digested at 37 ℃ for 1 hour, and the digested recombinant plasmid pCDFduet-cadA (R470E) was transformed into E.coli competent cells.
The transformation method comprises the following steps: 3ul of recombinant plasmid pCDFduet-cadA (R470E) is taken and transformed into 30ul of escherichia coli competent cells, the cells are kept still on ice for 20min, and immediately placed on ice for cooling for 5min after being heat-shocked in water bath at 42 ℃ for 50s, and 1ml of LB culture medium (without antibiotics) is added; shaking the bacteria at 37 ℃ and 200r/min for 1 h; centrifuging at 5000R/min for 3min, discarding 900ul of supernatant, resuspending the thallus with the rest culture medium, lightly spreading on streptomycin plate with sterile coating rod, culturing overnight at 37 deg.C by inversion in incubator, and selecting positive colony to obtain recombinant strain pCDFduet-cadA (R470E).
EXAMPLE 3 use of recombinant Strain pCDFduet-cadA (R470E) for the production of itaconic acid
The recombinant strain pCDFduet-cadA (R470E) was inoculated into 5ml of LB liquid medium at an inoculum size of 1%, cultured overnight at 37 ℃ and then inoculated into a new 100ml of LB liquid medium at an inoculum size of 1%, and cultured at 37 ℃ to OD600When the value of (A) is 0.6, inducing with 5 ‰ IPTG, and culturing at 18 deg.C for 18 h. Centrifuging at 4500r/min for 15min, removing supernatant, resuspending the thallus with PBS buffer solution, centrifuging at 5000r/min for 10min, using the thallus for whole cell reaction, wherein the reaction system comprises: 0.5M aconitic acid 400. mu.l, OD600 Reacting 60 bacteria liquid 1000 mul and PBS 600 mul in a shaking incubator at 35 ℃ and 200r/min for 24h, detecting the reaction liquid by a high performance liquid chromatograph, and detecting itaconic acid: aminex HPX-87H type chromatographic column (300X 7.8 mm, 9 μm) with a mobile phase of 0.008 mol/L sulfuric acid; flow rate 0.6 mL/min-1(ii) a The detection wavelength is 210 nm; the column oven temperature was 60 ℃. The results showed that the recombinant strain pCDFduet-cadA (R470E) produced a mutated aconitate decarboxylase whose enzyme has an increased itaconate-producing capacity of 28.74% at pH 5.0 and 8.43% at pH 5.5 (as shown in FIG. 3).
The above description is only a preferred embodiment of the present invention, and the scope of the present invention is not limited thereto, and any simple modifications or equivalent substitutions of the technical solutions that can be obviously obtained by those skilled in the art within the technical scope of the present invention are within the scope of the present invention.
Sequence listing
<110> Nanjing university of industry
<120> construction method of recombinant strain and application thereof in production of itaconic acid
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 36
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
ctggtgctgg gcctggatga actgacagat attagc 36
<210> 2
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
ggttcagggc agggtcgtta aat 23
<210> 3
<211> 490
<212> PRT
<213> amino acid Sequence (amino acid Sequence)
<400> 3
Met Thr Lys Gln Ser Ala Asp Ser Asn Ala Lys Ser Gly Val Thr Ser
1 5 10 15
Glu Ile Cys His Trp Ala Ser Asn Leu Ala Thr Asp Asp Ile Pro Ser
20 25 30
Asp Val Leu Glu Arg Ala Lys Tyr Leu Ile Leu Asp Gly Ile Ala Cys
35 40 45
Ala Trp Val Gly Ala Arg Val Pro Trp Ser Glu Lys Tyr Val Gln Ala
50 55 60
Thr Met Ser Phe Glu Pro Pro Gly Ala Cys Arg Val Ile Gly Tyr Gly
65 70 75 80
Gln Lys Leu Gly Pro Val Ala Ala Ala Met Thr Asn Ser Ala Phe Ile
85 90 95
Gln Ala Thr Glu Leu Asp Asp Tyr His Ser Glu Ala Pro Leu His Ser
100 105 110
Ala Ser Ile Val Leu Pro Ala Val Phe Ala Ala Ser Glu Val Leu Ala
115 120 125
Glu Gln Gly Lys Thr Ile Ser Gly Ile Asp Val Ile Leu Ala Ala Ile
130 135 140
Val Gly Phe Glu Ser Gly Pro Arg Ile Gly Lys Ala Ile Tyr Gly Ser
145 150 155 160
Asp Leu Leu Asn Asn Gly Trp His Cys Gly Ala Val Tyr Gly Ala Pro
165 170 175
Ala Gly Ala Leu Ala Thr Gly Lys Leu Leu Gly Leu Thr Pro Asp Ser
180 185 190
Met Glu Asp Ala Leu Gly Ile Ala Cys Thr Gln Ala Cys Gly Leu Met
195 200 205
Ser Ala Gln Tyr Gly Gly Met Val Lys Arg Val Gln His Gly Phe Ala
210 215 220
Ala Arg Asn Gly Leu Leu Gly Gly Leu Leu Ala His Gly Gly Tyr Glu
225 230 235 240
Ala Met Lys Gly Val Leu Glu Arg Ser Tyr Gly Gly Phe Leu Lys Met
245 250 255
Phe Thr Lys Gly Asn Gly Arg Glu Pro Pro Tyr Lys Glu Glu Glu Val
260 265 270
Val Ala Gly Leu Gly Ser Phe Trp His Thr Phe Thr Ile Arg Ile Lys
275 280 285
Leu Tyr Ala Cys Cys Gly Leu Val His Gly Pro Val Glu Ala Ile Glu
290 295 300
Asn Leu Gln Gly Arg Tyr Pro Glu Leu Leu Asn Arg Ala Asn Leu Ser
305 310 315 320
Asn Ile Arg His Val His Val Gln Leu Ser Thr Ala Ser Asn Ser His
325 330 335
Cys Gly Trp Ile Pro Glu Glu Arg Pro Ile Ser Ser Ile Ala Gly Gln
340 345 350
Met Ser Val Ala Tyr Ile Leu Ala Val Gln Leu Val Asp Gln Gln Cys
355 360 365
Leu Leu Ser Gln Phe Ser Glu Phe Asp Asp Asn Leu Glu Arg Pro Glu
370 375 380
Val Trp Asp Leu Ala Arg Lys Val Thr Ser Ser Gln Ser Glu Glu Phe
385 390 395 400
Asp Gln Asp Gly Asn Cys Leu Ser Ala Gly Arg Val Arg Ile Glu Phe
405 410 415
Asn Asp Gly Ser Ser Ile Thr Glu Ser Val Glu Lys Pro Leu Gly Val
420 425 430
Lys Glu Pro Met Pro Asn Glu Arg Ile Leu His Lys Tyr Arg Thr Leu
435 440 445
Ala Gly Ser Val Thr Asp Glu Ser Arg Val Lys Glu Ile Glu Asp Leu
450 455 460
Val Leu Gly Leu Asp Arg Leu Thr Asp Ile Ser Pro Leu Leu Glu Leu
465 470 475 480
Leu Asn Cys Pro Val Lys Ser Pro Leu Val
485 490
Claims (5)
1. A method for constructing a recombinant strain pCDFduet-cadA (R470E), which is characterized by comprising the following steps:
step 1, designing primers
Designing a mutation site by rational analysis of the aconitate decarboxylase gene cadA, and designing a primer by utilizing Snapgene software;
step 2, construction of recombinant plasmid
Carrying out site-directed mutagenesis by using the primer designed in the step 1, and carrying out mutagenesis by using pCDFduet-cadA as a template to obtain a recombinant plasmid pCDFduet-cadA (R470E);
step 3, obtaining recombinant strains
The recombinant plasmid pCDFduet-cadA (R470E) constructed in step 2 is transformed into competent cells of Escherichia coli, and cultured to obtain a recombinant strain pCDFduet-cadA (R470E).
2. The method for constructing a recombinant strain pCDFduet-cadA (R470E) according to claim 1, wherein the primers in step 1 are as follows:
R470E-F:5’-CTGGTGCTGGGCCTGGATGAACTGACAGATATTAGC-3’
R470E-R:5’-GGTTCAGGGCAGGGTCGTTAAAT-3’。
3. the method for constructing the recombinant strain pCDFduet-cadA (R470E) according to claim 1, wherein the two rounds of PCR amplification conditions of the mutation in step 2 are the same as the amplification system, and the amplification conditions are 95 ℃, 30s and 1 cycle; 95 ℃, 15s, 56 ℃, 15s, 72 ℃, 30s and 30 cycles; 72 ℃, 5min, 1 cycle; an amplification system: ddH2O20.5. mu.l, template 0.5. mu.l, corresponding primers 2. mu.l each, and 2xPhanta Max Master Mix (Dye Plus) 25. mu.l.
4. Use of the recombinant strain pCDFduet-cadA (R470E) obtained according to claim 1 for the production of itaconic acid.
5. The application of claim 4, comprising the following steps: firstly, transferring a recombinant strain pCDFduet-cadA (R470E) into 10ml of liquid LB culture medium according to the inoculation amount of 1%, carrying out shake culture at 37 ℃ overnight, transferring the recombinant strain pCDFduet-cadA into 100ml of liquid LB culture medium according to the inoculation amount of 1% the next day, carrying out shake culture at 37 ℃ for 18h, centrifuging at 4 ℃ and 4500R/min for 15min, discarding supernatant, re-suspending thallus by PBS buffer solution, centrifuging at 4 ℃ and 5000R/min for 10min, discarding supernatant, and configuring thallus into OD (OD) by PBS60060, preparing bacterial liquid for later use;
step two, reaction system: 0.5M aconitic acid 400. mu.l, OD600 1000 mul of 60 bacterium liquid, 600 mul of PBS and pH 5.5 are reacted for 24 hours in a shaking incubator with the temperature of 35 ℃ and the speed of 200r/min, the reaction liquid is detected by a high performance liquid chromatograph, and the method for detecting the itaconic acid comprises the following steps: aminex HPX-87H type chromatographic column (300X 7.8 mm, 9 μm) with a mobile phase of 0.008 mol/L sulfuric acid; flow rate 0.6 mL/min-1(ii) a The detection wavelength is 210 nm; the column oven temperature was 60 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111287718.XA CN113999807B (en) | 2021-11-02 | 2021-11-02 | Construction method of recombinant strain and application of recombinant strain in itaconic acid production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111287718.XA CN113999807B (en) | 2021-11-02 | 2021-11-02 | Construction method of recombinant strain and application of recombinant strain in itaconic acid production |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113999807A true CN113999807A (en) | 2022-02-01 |
CN113999807B CN113999807B (en) | 2023-04-25 |
Family
ID=79926948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111287718.XA Active CN113999807B (en) | 2021-11-02 | 2021-11-02 | Construction method of recombinant strain and application of recombinant strain in itaconic acid production |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113999807B (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009027999A (en) * | 2007-07-30 | 2009-02-12 | National Univ Corp Shizuoka Univ | Dna encoding cis-aconitic acid decarboxylase, method for producing the cis-aconitic acid decarboxylase, and method for producing itaconic acid |
CN103834582A (en) * | 2012-11-22 | 2014-06-04 | 中国科学院青岛生物能源与过程研究所 | Itaconic acid fermentation yield improvement bacterial strain, construction method thereof and itaconic acid production method using bacterial strain |
CN107058144A (en) * | 2017-02-15 | 2017-08-18 | 江南大学 | A kind of restructuring yeast strains for producing itaconic acid and its construction method and application |
CN108795789A (en) * | 2018-07-02 | 2018-11-13 | 山东省食品发酵工业研究设计院 | A kind of high-yield itaconic acid Yarrowia lipolytica engineered strain and its construction method, zymotechnique and application |
CN110527637A (en) * | 2019-07-18 | 2019-12-03 | 中国科学院青岛生物能源与过程研究所 | A kind of Aspergillus terreus bacterial strain producing aconitic acid and its construction method and application |
CN111944706A (en) * | 2020-08-06 | 2020-11-17 | 中国科学院青岛生物能源与过程研究所 | Recombinant aspergillus terreus strain for producing itaconic acid and construction method and application thereof |
CN112011470A (en) * | 2020-08-26 | 2020-12-01 | 中国科学院青岛生物能源与过程研究所 | Genetically engineered bacterium capable of highly producing trans-aconitic acid and construction method and application thereof |
CN112029670A (en) * | 2020-08-26 | 2020-12-04 | 中国科学院青岛生物能源与过程研究所 | Recombinant aspergillus terreus for high yield of itaconic acid and construction method and application thereof |
CN113481136A (en) * | 2021-07-19 | 2021-10-08 | 天津大学 | Recombinant halophilic monad, construction method and application of catalyzing citric acid to prepare itaconic acid |
CN114657075A (en) * | 2022-02-10 | 2022-06-24 | 天津科技大学 | Aspergillus niger strain for producing itaconic acid, method and application |
-
2021
- 2021-11-02 CN CN202111287718.XA patent/CN113999807B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009027999A (en) * | 2007-07-30 | 2009-02-12 | National Univ Corp Shizuoka Univ | Dna encoding cis-aconitic acid decarboxylase, method for producing the cis-aconitic acid decarboxylase, and method for producing itaconic acid |
CN103834582A (en) * | 2012-11-22 | 2014-06-04 | 中国科学院青岛生物能源与过程研究所 | Itaconic acid fermentation yield improvement bacterial strain, construction method thereof and itaconic acid production method using bacterial strain |
CN107058144A (en) * | 2017-02-15 | 2017-08-18 | 江南大学 | A kind of restructuring yeast strains for producing itaconic acid and its construction method and application |
CN108795789A (en) * | 2018-07-02 | 2018-11-13 | 山东省食品发酵工业研究设计院 | A kind of high-yield itaconic acid Yarrowia lipolytica engineered strain and its construction method, zymotechnique and application |
CN110527637A (en) * | 2019-07-18 | 2019-12-03 | 中国科学院青岛生物能源与过程研究所 | A kind of Aspergillus terreus bacterial strain producing aconitic acid and its construction method and application |
CN111944706A (en) * | 2020-08-06 | 2020-11-17 | 中国科学院青岛生物能源与过程研究所 | Recombinant aspergillus terreus strain for producing itaconic acid and construction method and application thereof |
CN112011470A (en) * | 2020-08-26 | 2020-12-01 | 中国科学院青岛生物能源与过程研究所 | Genetically engineered bacterium capable of highly producing trans-aconitic acid and construction method and application thereof |
CN112029670A (en) * | 2020-08-26 | 2020-12-04 | 中国科学院青岛生物能源与过程研究所 | Recombinant aspergillus terreus for high yield of itaconic acid and construction method and application thereof |
CN113481136A (en) * | 2021-07-19 | 2021-10-08 | 天津大学 | Recombinant halophilic monad, construction method and application of catalyzing citric acid to prepare itaconic acid |
CN114657075A (en) * | 2022-02-10 | 2022-06-24 | 天津科技大学 | Aspergillus niger strain for producing itaconic acid, method and application |
Non-Patent Citations (1)
Title |
---|
甘晟勋,等: "代谢工程改造大肠杆菌生产衣康酸", 《重 庆 理 工 大 学 学 报(自然科学)》 * |
Also Published As
Publication number | Publication date |
---|---|
CN113999807B (en) | 2023-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108424900B (en) | Nitrilase mutant and construction method and application thereof | |
CN105331642B (en) | Method for catalytically producing α -ketoglutaric acid by using L-glutamic acid oxidase | |
CN109266664B (en) | Method for improving stability of glutamate oxidase by using fusion truncated expression strategy | |
CN114134134B (en) | L-threonine aldolase mutant and application thereof in synthesis of L-syn-p-methylsulfonyl phenylserine | |
CN109593702B (en) | Method for synthesizing L-phenyllactic acid by whole cell transformation of genetic engineering strain | |
CN117778342B (en) | Carbonyl reductase mutant and application thereof in synthesis of 11 beta-hydroxy steroid compounds | |
CN113462677A (en) | Alpha subunit mutated nitrile hydratase mutant and application thereof | |
CN111154746B (en) | Amidase mutant and application thereof in catalytic synthesis of 2-chloronicotinic acid | |
CN101469318B (en) | Synthesis of (R)-styrene glycol by coupling acceleration of (R)-carbonyl reduction enzyme and formic dehydrogenase | |
CN108103049B (en) | Thermophilic L-asparaginase mutant and screening and fermenting method thereof | |
CN101368168B (en) | Method for preparing (S)-styrene glycol with carbonyl reduction enzyme coupled with pyrimidine nucleoside acid transhydrogenase | |
CN113999807A (en) | Construction method of recombinant strain and application of recombinant strain in production of itaconic acid | |
CN110004120A (en) | A kind of recombination aldehyde Ketoreductase mutant and application | |
CN106119272B (en) | Strategy for efficiently co-producing L-phenylglycine and gluconic acid | |
CN104830744A (en) | Method for preparing (R)-phenylglycol from SD-AS sequence coupled (R)-carbonyl reductase and glucose dehydrogenase | |
US11760988B2 (en) | L-aspartate alpha-decarboxylase mutant and application thereof | |
CN104130998B (en) | Pseudomonas putida nitrilase mutant strain obtained by site-directed mutagenesis and construction method thereof | |
CN106916840A (en) | A kind of nitrilase gene engineering bacteria and its construction method, fermentation culture method and application | |
Jeong et al. | Influence of Vitreoscilla hemoglobin gene expression on 2, 3-butanediol production in Klebsiella oxytoca | |
CN115011536B (en) | Engineering bacterium for producing high optical purity D-lactic acid by double anaerobic promoters and preparation method and application thereof | |
CN111575258B (en) | Carbonyl reductase EbSDR8 mutant and construction method and application thereof | |
CN114395573B (en) | Method for improving yield of itaconic acid produced by whole cell catalysis by utilizing aconitic acid decarboxylase | |
CN115747194B (en) | L-threonine aldolase mutant, gene and method for preparing L-anti-p-methylsulfonylphenyl serine | |
CN118222540A (en) | Heat-resistant plastic hydrolase AtPETase mutant and application thereof | |
CN118240807A (en) | Nitrilase mutant with improved heat stability and application thereof in synthesis of 2-chloronicotinic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20220201 Assignee: Wuhan Kaiming Biotechnology Co.,Ltd. Assignor: Nanjing Tech University Contract record no.: X2024980000326 Denomination of invention: Construction method of a recombinant strain and its application in the production of itaconic acid Granted publication date: 20230425 License type: Common License Record date: 20240110 |
|
EE01 | Entry into force of recordation of patent licensing contract |